1. Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
   Zhibo He et al, 2023, Scientific Reports CrossRef
2. Combination Blockade of the IL6R/STAT-3 Axis with TIGIT and Its Impact on the Functional Activity of NK Cells against Prostate Cancer Cells
   S. González-Ochoa et al, 2022, Journal of Immunology Research CrossRef
3. Glyoxalase-1-Dependent Methylglyoxal Depletion Sustains PD-L1 Expression in Metastatic Prostate Cancer Cells: A Novel Mechanism in Cancer Immunosurveillance Escape and a Potential Novel Target to Overcome PD-L1 Blockade Resistance
   Cinzia Antognelli et al, 2021, Cancers CrossRef
4. Astragaloside IV-PESV Repressed T Cell Immunosuppression by Inhibiting PD-L1 Expression in Prostate Cancer through STAT3 Pathway
   Xujun You et al, 2023, Journal of Food Biochemistry CrossRef
5. The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors
   Maria Teresa Palano et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
6. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic–Pathologic Correlations
   Andrea Palicelli et al, 2021, Cells CrossRef
7. Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
   Amber B. Jones et al, 2022, Cancers CrossRef
8. Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
   Rosa A. Castillo-Rodríguez et al, 2022, Cancers CrossRef
9. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1
   Andrea Palicelli et al, 2021, International Journal of Molecular Sciences CrossRef
10. The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance
    Agnieszka Witalisz-Siepracka et al, 2022, Frontiers in Immunology CrossRef
11. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)
    Andrea Palicelli et al, 2021, International Journal of Molecular Sciences CrossRef
12. Emerging Proteins in CRPC: Functional Roles and Clinical Implications
    Piaoping Kong et al, 2022, Frontiers in Oncology CrossRef
13. Post-Translational Modifications That Drive Prostate Cancer Progression
    Ivana Samaržija, 2021, Biomolecules CrossRef
14. HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer
    Erasmia T. Xanthopoulou et al, 2023, Medical Oncology CrossRef
15. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, BRCA, PTEN, and Other Genes
    Andrea Palicelli et al, 2022, Biomedicines CrossRef
16. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
    Ping-Lian Yang et al, 2020, Cancers CrossRef
17. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment
    Andrea Palicelli et al, 2021, International Journal of Molecular Sciences CrossRef
18. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables
    Andrea Palicelli et al, 2021, Cells CrossRef